BUY Ajanta Pharma Limited — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)6 May 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Cipla, Ajanta Pharma to Alkem Laboratories: Pharma stocks rise amid weak trends on Dalal Street
NewsLivemint·20 Jul · today
2 advisors have active short-term BUY calls on this stock
Advisor consensus · adjacent horizon·7 Jul · 2w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Ajanta Pharma
- BUY — Manas Jaiswal23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY — Aastha Jain, Hem Securities30 Sept 2026 · Next day · target ₹3,800 · SL hit
- BUY — Sahi Research24 Sept 2026 · ~2 weeks · target ₹3,780 · SL hit
- BUY — Siddharth Rai Mangala18 Sept 2026 · ~2 weeks · target ₹3,770 · SL hit
- BUY — Kshitija Salvi, Globe Capital Market8 Sept 2026 · ~2 weeks · target ₹3,825 · SL hit
More from ICICI Securities
- BUY The Indian Hotels Company22 Oct 2026 · ~1 year · target ₹969 · Active
- BUY Just Dial21 Oct 2026 · ~1 year · target ₹850 · Active
- BUY Union Bank of India20 Oct 2026 · ~1 year · target ₹230 · Active
- BUY Rossari Biotech20 Oct 2026 · ~1 year · target ₹520 · Active
- BUY Tatva Chintan Pharma Chem20 Oct 2026 · ~1 year · target ₹2,385 · Active

